What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport®

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 1, 1998, Pages 13-17

  Poewe, W ^a,i   Deuschl, G ^c,d   Nebe, A ^a   Feifel, E ^c   Wissel, J ^a   Benecke, R ^b,h   Kessler, K R ^b   Ceballos Baumann, A O ^f   Ohly, A ^f   Oertel, W ^e,g   Kunig G ^e  

^a HUMBOLDT UNIVERSITY   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f Chirurgische Klinik und Poliklinik   (Germany)

^g PHILIPPS UNIVERSITY MARBURG   (Germany)

^h UNIVERSITY OF ROSTOCK   (Germany)

ⁱ UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Botulinum toxin A; Cervical dystonia; Dose range

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; BREATHING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPHAGIA; FATIGUE; FEMALE; FEVER; HEADACHE; HOARSENESS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TORTICOLLIS; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

EID: 6844266275     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.1.13     Document Type: Article

References (23)

1. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988;3:188-94.
2. Tsui JKC, Eisen A, Stoessel AJ, Calne S. Double blind study of botulinum toxin in spasmodic torticollis. Lancet 1986;11:245-6.
3. Gelb DJ, Lowenstein DH, Aminoff M. Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis. Neurology 1989;39:80-4.
4. Lorentz IT, Shanti Subramaniam S, Yiannikas C. Treatment of idiopathic spasmodic torticollis with botulinum toxin A: a double blind study on 23 patients. Mov Disord 1991;6:145-50.
5. Blackie JD, Lees AJ. Botulinum toxin treatment in spasmodic torticollis. J Neurol Neurosurg Psychiatry 1990; 53:640-3.
6. Greene P, Kang U, Fahn S, Brin M, Moskowitz C, Flaster E. Double blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis. Neurology 1990;40:1213-8.
7. Perlmutter JS, Tempel LW, Burde R. Double-blind, placebo-controlled, crossover trial of botulinum A toxin for torticollis. Neurology 1989;39:352.
8. Gelb DJ, Yoshimura DM, Olney RK, Lowenstein DH, Aminoff MJ. Change in pattern of muscle activity following botulinum toxin injections for torticollis. Ann Neurol 1991; 29:370-6.
9. Moore AP, Blumhardt LD. A double blind trial of botulinum toxin A in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry 1991;34:813-6.
10. Tsui JK, Eisen A, Calne DB. Botulinum toxin in spasmodic torticollis. Adv Neurol 1988;50:593-7.
11. Poewe W, Schelosky L, Kleedorfer B. Treatment of spasmodic torticollis with local injection of botulinum toxin - one year follow up in 37 patients. J Neurol 1992;1: 21-6.
12. Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990;50:633-9.
13. Jankovic J, Schwartz K. Botulinum toxin treatment for cervical dystonia. Neurology 1990;40:277-80.
14. Brin MF, Fahn S, Moskowitz C, Friedman A, Shale HM, Greene P, Blitzer A. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Diord 1987;2:237-54.
15. Wissel J, Poewe W. Dystonia - a clinical, neuropathological and therapeutic review. J Neural Transm Gen Sect 1992;38: 91-104.
16. Stell R, Thompson PD, Marsden CD. Botulinum toxin in spasmodic torticollis J Neurol Neurosurg Psychiatry 1988; 51:920-3.
17. D'Costa DF, Abbott RJ. Low dose botulinum toxin in spasmodic torticollis J R Soc Med 1991;84:650-1.
18. Lees AJ, Turjanski N, Rivest J, Whurr R, Lorch M, Brookes G. Treatment of cervical dystonia, hand spasms and laryngeal dystonia with botulinum toxin. J Neurol 1992;239:1-4.
19. Poewe W, Wissel J. Experience with botulinum toxin in cervical dystonia. In: Joseph Jankovic, Mark Hallett, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994:267-78.
20. Borodic GE, Ferrante R, Pearce LB, Smith K. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum-A-toxin injection. Mov Disord 1994;9:31-9.
21. Comella CL, Tanner CM, DeFoor-Hill L, Smith CS. Dysphagia after toxin treatment of spasmodic trorticollis. Neurology 1990;(suppl 1):40:382.
22. Whurr R, Kingsley D, Massarei A. The incidence and nature of dysphagia in patients with spasmodic torticollis (ST) treated with botulinum injections. Mov Disord 1995;10:388.
23. Bhatia KP, Whurr R, Pramstaller PP, Marsden CD. A prospective investigation of the incidence of dysphagia in patients with spasmodic torticollis treated with botulinum toxin injections. Mov Disord 1995;10:388.